Patent application filed

October, 2019

A new patent application is filed, YEAST FOR THE TREATMENT OF ALLERGY. The patent application was based on an (in vivo) allergy study conducted in 2017 and in vitro studies at Sapienza University.

Results from In vitro study

September, 2019

Sapienza reports in vitro studies showing that the dry form of Milmed shows the same and partly better results than Milmed as a suspension.

Report from study of toxicity

July, 2019

Professor Businaro reports in vitro studies showing that Milmed has no toxicity and Milmed is harmless towards animals, humans and plants.

New agreement with Sapienza University

April, 2019

A renewed research agreement has been signed with Sapienza University of Rome, Department of Medico-Surgical Sciences and Biotechnologies. The research leader is still Professor Rita Businaro, and she’s looking forward to continuing her research.